Quarterly Results

ERIS LIFESCIENCES LTD.

NSE : ERISBSE : 540596ISIN CODE : INE406M01024Industry : Pharmaceuticals & DrugsHouse : Private
BSE892.6010 (+1.13 %)
PREV CLOSE ( ) 882.60
OPEN PRICE ( ) 882.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2521
TODAY'S LOW / HIGH ( )877.00 896.40
52 WK LOW / HIGH ( )605.2 971
NSE892.959.35 (+1.06 %)
PREV CLOSE( ) 883.60
OPEN PRICE ( ) 884.60
BID PRICE (QTY) 892.95 (218)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 58767
TODAY'S LOW / HIGH( ) 875.00 897.30
52 WK LOW / HIGH ( )605 971.9
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
Audited
Net Sales
4862.97
5052.99
4666.22
4027.98
Total Expenditure
3107.88
3241.55
2968.77
2839.04
PBIDT (Excl OI)
1755.09
1811.44
1697.45
1188.94
Other Income
41.97
34.81
9.89
10.04
Operating Profit
1797.06
1846.25
1707.34
1198.98
Interest
181.18
162.95
173.56
88.67
Exceptional Items
NA
NA
NA
NA
PBDT
1615.88
1683.3
1533.78
1110.31
Depreciation
457.16
420.94
408.94
351.3
Profit Before Tax
1158.72
1262.36
1124.84
759.01
Tax
144.12
39.24
188.35
144.23
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
1014.6
1223.12
936.49
614.78
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
1014.6
1223.12
936.49
614.78
Minority Interest
12.76
11.18
12.06
39.4
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
1027.36
1234.3
948.55
654.18
Equity Capital
136.03
136.02
135.99
135.99
Face Value (IN RS)
1
1
1
1
Reserves
NA
NA
NA
NA
Calculated EPS
7.55
9.07
6.97
4.81
Calculated EPS (Annualised)
30.20
36.29
27.90
19.24
No of Public Share Holdings
61344536
61339504
64109648
64108594
% of Public Share Holdings
45.1
45.09
47.14
47.14
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
36.09
35.84
36.37
29.51
PBIDTM%
36.95
36.53
36.58
29.76
PBDTM%
33.22
33.31
32.86
27.56
PBTM%
23.82
24.98
24.10
18.84
PATM%
20.86
24.20
20.06
15.26
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.